High-turnover osteoporosis is induced by cyclosporin A in rats

Journal of Bone and Mineral Metabolism

Volumn 24, Issue 3, 2006, Pages 199-205

  Wada, Chie ^a   Kataoka, Masatoshi ^a   Seto, Hiroyuki ^a   Hayashi, Noriko ^a   Kido, Jun Ichi ^a   Shinohara, Yasuo ^a,b   Nagata, Toshihiko ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

Author keywords

CT; Cyclosporin A; Osteoporosis; Parathyroid hormone

Indexed keywords

CATHEPSIN K; CYCLOSPORIN A; MESSENGER RNA; OSTEOCALCIN; OSTEOPONTIN; PARATHYROID HORMONE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL DIET; BONE MARROW; BONE MASS; BONE REMODELING; BONE TURNOVER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIETARY INTAKE; DRUG EFFECT; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; HORMONE DETERMINATION; MALE; MICROSCOPY; MORPHOMETRICS; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; OSTEOPOROSIS; POWDER; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RAT; TIBIA;

ANIMALS; BONE REMODELING; BONE RESORPTION; CYCLOSPORINE; GINGIVAL OVERGROWTH; IMMUNOSUPPRESSIVE AGENTS; MALE; OSTEOCALCIN; OSTEOGENESIS; OSTEOPOROSIS; PARATHYROID HORMONE; RATS; RATS, INBRED F344; TIBIA; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33645842236     PISSN: 09148779     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00774-005-0672-x     Document Type: Article

References (45)

1. EM Shevach 1985 The effects of cyclosporin A on the immune system Annu Rev Immunol 3 397 423
2. MJ Farthing ML Clark 1981 Nature of the toxicity of cyclosporin A in the rat Biochem Pharmacol 30 3311 3316
3. TD Daley GP Wysocki 1984 Cyclosporine therapy. Its significance to the periodontist J Periodontol 55 708 712
4. PM Bartold 1987 Cyclosporine and gingival overgrowth J Oral Pathol 16 463 468
5. MA Rodino E Shane 1998 Osteoporosis after organ transplantation Am J Med 104 459 469
6. S Epstein 1996 Post-transplantation bone disease: the role of immunosuppressive agents and the skeleton J Bone Miner Res 11 1 7
7. AM Cueto-Manzano S Konel AJ Hutchinson V Crowley MW France AJ Freemont JE Adams B Mawer R Gokal 1999 Bone loss in long-term renal transplantation: histopathology and densitometry analysis Kidney Int 55 2021 2029
8. S Durieux L Mercadal P Orcel H Dao C Rioux M Bernald S Rozenberg B Barrou P Bourgeois G Deray CI Bagnis 2002 Bone mineral density and fracture prevalence in long-term kidney graft recipients Transplantation 74 496 500
9. JE Compston 2003 Osteoporosis after liver transplantation Liver Transpl 9 321 330
10. K Meeran A Hattersley J Burrin R Shiner K Ibbertson 1995 Oral and inhaled corticosteroids reduce bone formation as shown by plasma osteocalcin levels Am J Respir Crit Care Med 151 333 336
11. CS King EC Weir CW Gundberg J Fox KL Insogna 1996 Effects of continuous glucocorticoid infusion on bone metabolism in the rat Calcif Tissue Int 59 184 191
12. PJ Stewart OC Green PH Stern 1986 Cyclosporine A inhibits calcemic hormone-induced bone resorption in vitro J Bone Miner Res 1 285 291
13. C Movsowitz S Epstein M Fallon F Ismail S Thomas 1988 Cyclosporin-A in vivo produces severe osteopenia in the rat: effect of dose and duration of administration Endocrinology 123 2571 2577
14. P Orcel J Bielakoff D Modrowski L Miravet MC de Vernejoul 1989 Cyclosporin A induces in vivo inhibition of resorption and stimulation of formation in rat bone J Bone Miner Res 4 387 391
15. L Klein MS Lemel MS Wolfe J Shaffer 1994 Cyclosporin A does not affect the absolute rate of cortical bone resorption at the organ level in the growing rat Calcif Tissue Int 55 295 301
16. M Kataoka Y Shimizu K Kunikiyo Y Asahara K Yamashita M Ninomiya I Morisaki Y Ohsaki J Kido T Nagata 2000 Cyclosporin A decreases the degradation of type I collagen in rat gingival overgrowth J Cell Physiol 182 351 358
17. I Morisaki K Kitamura K Kato Y Marukawa J Mihara 1993 Age dependency of cyclosporin A-induced gingival overgrowth in rats Pediatr Dent 15 414 417
18. JH Waarsing JS Day JC van der Linden AG Ederveen C Spanjers N De Clerck A Sasov JA Verhaar H Weinans 2004 Detecting and tracking local changes in the tibiae of individual rats: a novel method to analyse longitudinal in vivo micro-CT data Bone 34 163 169
19. JC Fleet JM Hock 1994 Identification of osteocalcin mRNA in nonosteoid tissue of rats and humans by reverse transcription-polymerase chain reaction J Bone Miner Res 9 1565 1573
20. W Huang GH Rudkin B Carlsen K Ishida P Ghasri B Anvar DT Yamaguchi TA Miller 2002 Overexpression of BMP-2 modulates morphology, growth, and gene expression in osteoblastic cells Exp Cell Res 274 226 234
21. M Komine A Kukita T Kukita Y Ogata T Hotokebuchi O Kohashi 2001 Tumor necrosis factor-α cooperates with receptor activator of nuclear factor kB ligand in generation of osteoblasts in stromal cell-depleted rat bone marrow cell culture Bone 28 474 483
22. S Nishikawa T Nagata I Morisaki T Oka H Ishida 1996 Pathogenesis of drug-induced gingival overgrowth. A review of studies in the rat model J Periodontol 67 463 471
23. M Schlosberg C Movsowitz S Epstein F Ismal MD Fallon S Thomas 1989 The effect of cyclosporin A administration and its withdrawal on bone mineral metabolism in the rat Endocrinology 124 2179 2184
24. JE Compston S Greer SJ Skingle DM Stirling C Price PJ Friend G Alexander 1996 Early increase in plasma parathyroid hormone levels following liver transplantation J Hepatol 25 715 718
25. S Giannini A D'Angelo G Carraro A Antonello D Di Landro F Marchini M Plebani M Zaninotto P Rigotti L Sartori G Crepaldi 2001 Persistently increased bone turnover and low bone density in long-term survivors of kidney transplantation Clin Nephrol 56 353 363
26. S Epstein IR Dissanayake GR Goodman AR Bowman H Zhou Y Ma WS Jee 2001 Effect of the interaction of parathyroid hormone and cyclosporine A on bone mineral metabolism in the rat Calcif Tissue Int 68 240 247
27. H Seto K Aoki S Kasugai K Ohya 1999 Trabecular bone turnover, bone marrow cell development, and gene expression of bone matrix proteins after low calcium feeding in rats Bone 25 687 695
28. B Stein BP Halloran T Reinhardt GW Engstrom CW Bales MK Drezner KL Currie M Takizawa JS Adams S Epstein 1991 Cyclosporin-A increases synthesis of 1, 25-dihydroxyvitamin D3 in the rat and mouse Endocrinology 128 1369 1373
29. J Silver C Yalcindag A Sela-Brown R Kilav T Naveh-Many 1999 Regulation of the parathyroid hormone gene by vitamin D, calcium and phosphate Kidney Int Suppl 73 S2 S7
30. ME Holtrop GJ King KA Cox B Reit 1979 Time-related changes in the ultrastructure of osteoclasts after injection of parathyroid hormone in young rats Calcif Tissue Int 27 129 135
31. D von Stechow D Zurakowski AR Pettit R Muller G Gronowicz M Chorev H Out T Libermann JM Alexander 2004 Differential transcriptional effects of PTH and estrogen during anabolic bone formation J Cell Biochem 93 476 490
32. M Zaidi B Troen BS Moonga E Abe 2001 Cathepsin K, osteoclastic resorption, and osteoporosis therapy J Bone Miner Res 16 1747 1749
33. T Nagata HA Goldberg Q Zhang C Domenicucci J Sodek 1991 Biosynthesis of bone proteins by fetal porcine calvariae in vitro. Rapid association of sulfated sialoproteins (secreted phosphoprotein-1 and bone sialoprotein) and chondroitin sulfate proteoglycan (CS-PGIII) with bone mineral Matrix 11 86 100
34. KL Yao R Todescan Jr J Sodek 1994 Temporal changes in matrix protein synthesis and mRNA expression during mineralized tissue formation by adult rat bone marrow cells in culture J Bone Miner Res 9 231 240
35. D Ikedo K Ohishi N Yamauchi M Kataoka J Kido T Nagata 1999 Stimulatory effects of phenytoin on osteoblastic differentiation of fetal rat calvaria cells in culture Bone 25 653 660
36. 3H]bovine parathyroid hormone in bone by light microscope autoradiography Calcif Tissue Int 37 441 446
37. K Irie H Ozawa 1996 Immunohistochemical location of parathyroid hormone/parathyroid hormone-related peptide receptor in rat tibiae J Bone Miner Metab 14 10 14
38. S Kirino J Fukunaga S Ikegami H Tsuboi M Kimata N Nakata M Nakano T Ueno N Mizukawa T Sugahara 2004 Regulation of bone metabolism in immunosuppressant (FK506)-treated rat J Bone Miner Metab 22 554 560
39. Y Kobayashi S Ueyama Y Arai Y Yoshida T Kaneda T Sato K Shin M Kumegawa Y Hakeda 2004 The active metabolite of leflunomide, A771726, inhibits both the generation of and the bone-resorbing activity of osteoclasts by acting directly on cells of the osteoclast lineage J Bone Miner Metab 22 318 328
40. RR Bartlett R Schleyerbach 1985 Immunopharmacological profile of a novel isoxazol derivative, HWA486, with potential antirheumatic activity. 1. Disease modifying action on adjuvant arthritis of the rat Int J Immunopharmacol 7 7 18
41. S Ueyama Y Arai Y Yoshida H Kitagawa N Inazu M Yaguchi 1999 Leflunomide inhibits loss of bone mineral density and the reduction of bone mechanical strength in rats with adjuvant-induced arthritis Ann Rheum Dis 59 144
42. M Herrman R Schleyerbach BJ Kirschbaum 2000 Leflunomide: an immunomodulatory drug for the treatment of rheumatoid arthritis and other autoimmune diseases Immunopharmacology 47 273 289
43. W Knecht M Loffler 1998 Species-related inhibition of human and rat dihydroorotate dehydrogenase by immunosuppressive isoxazol and cinchoninic acid derivatives Biochem Pharmacol 56 1259 1264
44. J Liu JD Farmer WS Lane J Friedman I Weissman SL Schreiber 1991 Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes Cell 66 807 815
45. SJ O'Keefe J Tamura RL Kincaid MJ Tocci EA O'Neill 1992 FK506 and CsA sensitive activation of the interleukin-2 promoter by calcineurin Nature 357 692 694